As of 2025-11-09, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (184.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.07 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -2710.4%.
The range of the Relative Valuation is (184.80) - (184.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 15.3x | 15.2x |
| Forward P/E multiples | 15.3x - 15.4x | 15.4x |
| Fair Price | (184.80) - (184.31) | (184.56) |
| Upside | -2713.8% - -2707.0% | -2710.4% |
| Date | P/E |
| 2025-11-05 | -0.61 |
| 2025-11-04 | -0.60 |
| 2025-11-03 | -0.62 |
| 2025-10-31 | -0.68 |
| 2025-10-30 | -0.68 |
| 2025-10-29 | -0.71 |
| 2025-10-28 | -0.77 |
| 2025-10-27 | -0.81 |
| 2025-10-24 | -0.80 |
| 2025-10-23 | -0.79 |
| 2025-10-22 | -0.82 |
| 2025-10-21 | -0.87 |
| 2025-10-20 | -0.87 |
| 2025-10-17 | -0.83 |
| 2025-10-16 | -0.87 |
| 2025-10-15 | -0.86 |
| 2025-10-14 | -0.80 |
| 2025-10-13 | -0.79 |
| 2025-10-10 | -0.78 |
| 2025-10-09 | -0.85 |
| 2025-10-08 | -0.82 |
| 2025-10-07 | -0.82 |
| 2025-10-06 | -0.85 |
| 2025-10-03 | -0.83 |
| 2025-10-02 | -0.85 |
| 2025-10-01 | -0.85 |
| 2025-09-30 | -0.81 |
| 2025-09-29 | -0.80 |
| 2025-09-26 | -0.81 |
| 2025-09-25 | -0.78 |
| 2025-09-24 | -0.89 |
| 2025-09-23 | -0.85 |
| 2025-09-22 | -0.79 |
| 2025-09-19 | -0.80 |
| 2025-09-18 | -0.83 |
| 2025-09-17 | -0.76 |
| 2025-09-16 | -0.74 |
| 2025-09-15 | -0.78 |
| 2025-09-12 | -0.85 |
| 2025-09-11 | -0.90 |
| 2025-09-10 | -0.89 |
| 2025-09-09 | -0.93 |
| 2025-09-08 | -0.92 |
| 2025-09-05 | -0.94 |
| 2025-09-04 | -0.89 |
| 2025-09-03 | -0.90 |
| 2025-09-02 | -0.88 |
| 2025-08-29 | -0.87 |
| 2025-08-28 | -0.92 |
| 2025-08-27 | -0.94 |